-
Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.
Teen birth rates in the United States are dropping sharply, especially among Hispanic teens, according to a new government report.
The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or not exercising.
The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or not exercising.
When a classmate commits suicide, teens are more likely to consider or attempt suicide themselves, according to a new study.
When a classmate commits suicide, teens are more likely to consider or attempt suicide themselves, according to a new study.
Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.
Pregnant women with specific alterations in two genes may be at increased risk of suffering depression after giving birth, a small new study suggests.
Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.
Although spring arrived late this year in parts of the United States, the summer allergy season will still be strong, according to a sinus expert at the University of Alabama at Birmingham.
Information contained on this page is provided by companies via press release distributed through PR Newswire, an independent third-party content provider. PR Newswire, WorldNow and this Station make no warranties or representations in connection therewith.
SOURCE Oncothyreon Inc.
SEATTLE, WA, Feb. 27, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY)
announced today that Robert Kirkman, M.D., President and Chief
Executive Officer, will present at the Cowen and Company 33rd Annual Health Care Conference in Boston on Wednesday, March 6, 2013 at
8 a.m. Eastern.
A live and archived webcast of the presentation will be accessible by
visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
©2012 PR Newswire. All Rights Reserved.
